Image-empty-state_edited.jpg
Our take:
Smardii is pre-revenue and bills itself as a COVID-19 solution. The product seems like an easy add on that can quickly improve quality of life for patients.

Thanks, catch you soon!

Sign up to receive weekly deal alerts and top news

Round Performance

Amount Raised

[]

Average-Investment-Icon-p-1600.png
Average Investment

[]

Average-Daily-Investment-Icon-p-1600.png
Average Per Day

[]

Investors-Icon-p-1600.png
# of Investors

[]

Investors vs. Capital Raised

Investment Type

Common Stock

Round Valuation

$12,000,000

Minimum Investment

$

249

Price Per Share

$3

Investment Details

Early Bird Perks

Perk description
Perk level (dollars)
Perk level (days)
Loading...

No early bird perks for this round!

Screen Shot 2020-07-15 at 12.01.28 PM.pn

View early bird perks, company financials, valuation methods, and more

Smardii

Smardii Common Stock 1
A New Standard of Care for Elderlies

HYDRA

01/19 - 01/23

Click here to add your own content, or connect to data from your collections.

From:

$550

Book Now

SANTORINI

01/19 - 01/23

Click here to add your own content, or connect to data from your collections.

From:

$399

Book Now

MYKONOS

01/19 - 01/23

Click here to add your own content, or connect to data from your collections.

From:

$499

Book Now